Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
qi ju gan lu yin
- Development stage
- Unknown
- Lead developer
- Singapore Eye Research Institute
- Administration
- Oral
01
Overview
Qi Ju Gan Lu Yin is a Traditional Chinese Medicine (TCM) herbal supplement developed through a collaboration between the Singapore Eye Research Institute (SERI) and the Singapore Chung Hwa Medical Institution (SCHMI). It is an 11-ingredient formulation specifically designed to treat dry eye syndrome, particularly the lung and kidney yin deficiency patterns frequently observed in peri- and post-menopausal women. The supplement contains key botanical ingredients such as Chrysanthemum (Flos Chrysanthemi), Goji berries (Fructus Lycii), and baby ginseng (Radix Pseudostellariae). Clinical research indicates that the formula works by increasing supportive proteins and decreasing inflammatory proteins on the ocular surface, thereby improving tear film stability and reducing symptoms of irritation. It has been approved by the Singapore Health Sciences Authority (HSA) and is currently being evaluated in expanded clinical trials to assess its efficacy compared to standard treatments and acupuncture.
- Brand names
- Qi Ju Gan Lu Yin
- Other names
- Chi-Ju-Gan-Lu-Yin杞菊甘露饮
Beyond the preview
Go deeper on qi ju gan lu yin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on qi ju gan lu yin.